Co-infection of malaria and γ-herpesvirus: Exacerbated lung inflammation or cross-protection depends on the stage of viral infection

Clinical and Experimental Immunology

Volumn 138, Issue 3, 2004, Pages 396-404

  Haque, Azizul ^a,b   Rachinel, N ^a   Quddus, M R ^c   Haque, S ^a   Kasper, L H ^a   Usherwood, E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b INSTITUT PASTEUR DE LILLE   (France)

^c BROWN UNIVERSITY   (United States)

Author keywords

CD8+ T cell response; Inflammation; Parasite; Protection; Virus

Indexed keywords

CD8 ANTIGEN; PEPTIDE DERIVATIVE; TETRAMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HERPES; HERPES VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA; MEGAKARYOCYTE; MORTALITY; MOUSE; MURINE GAMMA HERPESVIRUS 68; NEUTROPHIL; NONHUMAN; PARASITEMIA; PLASMODIUM YOELII; PNEUMONIA; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD; VIRUS STRAIN;

ACUTE DISEASE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HERPESVIRIDAE INFECTIONS; INFLAMMATION; LUNG; MALARIA; MICE; MICE, INBRED BALB C; PARASITEMIA; PLASMODIUM YOELII; RNA, MESSENGER; RNA, VIRAL; VIRUS LATENCY;

EID: 9644289211     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02652.x     Document Type: Article

References (40)

1. Stiller CA, Parkin DM. Geographie and ethnic variations in the incidence of childhood cancer. Br Med Bull 1996; 52:682-703.
2. de The G. The etiology of Burkitt's lymphoma and the history of the shaken dogmas. Blood Cells 1993; 19:667-73.
3. de The G. Co-carcinogenic events in herpesvirus oncogenesis: a review. IARC Sci Publ 1978; 933-45.
4. Virgin HW, Speck SH. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr Opin Immunol 1999; 11:371-9.
5. Nash AA, Dutia BM, Stewart JP, Davison AJ. Natural history of murine gammaherpesvirus infection. Philos Trans R Soc Lond B Biol Sci 2001; 356:569-79.
6. Doherty PC, Christensen JP, Belz GT, Stevenson PG, Sangster MY. Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001; 356:581-93.
7. Wang R, Charoenvit Y, Daly TM, Long CA, Corradin G, Hoffman SL. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine. Immunol Lett 1996; 53:83-93.
8. Kang Y, Calvo PA, Daly TM, Long CA. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite. J Immunol 1998; 161:4211-9.
9. Brahimi K, Badell E, Sauzet JP et al. Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo. Infect Immun 2001; 69:3845-52.
10. Pasquetto V, Guidotti LG, Kakimi K, Tsuji M, Chisari FV. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J Exp Med 2000; 192:529-36.
11. Freitag C, Chougnet C, Schito M et al. Malaria infection induces virus expression in human immunodeficiency virus transgenic mice by CD4 T cell-dependent immune activation. J Infect Dis 2001; 183:1260-8.
12. Hoffman IF, Jere CS, Taylor TE et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. Aids 1999; 13:487-94.
13. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. Aids 1995; 9:721-6.
14. Steketee RW, Wirima JJ, Bloland PB et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 1996; 55:42-9.
15. Xiao L, Owen SM, Rudolph DL, Lal RB, Lal AA. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis 1998; 177:437-45.
16. Sunil-Chandra NP, Efstathiou S, Arno J, Nash AA. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol 1992; 73:2347-56.
17. Usherwood EJ, Ward KA, Blackman MA, Stewart JP, Woodland DL. Latent antigen vaccination in a model gammaherpesvirus infection. J Virol 2001; 75:8283-8.
18. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41:467-70.
19. Kappler JW, Skidmore B, White J, Marrack P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med 1981; 153:1198-214.
20. Usherwood EJ, Roy DJ, Ward K et al. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med 2000; 192:943-52.
21. Altman JD, Moss PH, Goulder PR et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274:94-6.
22. Lucas B, Kasper LH, Smith K, Haque A. In vivo treatment with interleukin 2 reduces parasitemia and restores IFN-gamma gene expression and T-cell proliferation during acute murine malaria. C R Acad Sci III 1996; 319:705-10.
23. Stevenson PG, Belz GT, Altman JD, Doherty PC. Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol 1999; 29:1059-67.
24. Tibbetts SA, van Dyk LF, Speck SH, Virgin HW. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol 2002; 76:7125-32.
25. Usherwood EJ. A new approach to epitope confirmation by sampling effector/memory T cells migrating to the lung. J Immunol Methods 2002; 266:135-42.
26. Husain SM, Usherwood EJ, Dyson H et al. Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A 1999; 96:7508-13.
27. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002; 2:417-26.
28. Kramer B, Grobusch MP, Suttorp N, Neukammer J, Rinneberg H. Relative frequency of malaria pigment-carrying monocytes of nonimmune and semi-immune patients from flow cytometric depolarized side scatter. Cytometry 2001; 45:133-40.
29. Graca-Souza AV, Arruda MA, de Freitas MS, Barja-Fidalgo C, Oliveira PL. Neutrophil activation by heme: implications for inflammatory processes. Blood 2002; 99:4160-5.
30. Zucker-Franklin D, Philipp CS. Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept. Am J Pathol 2000; 157:69-74.
31. Moerman F, Colebunders B, D'Alessandro U. Thrombocytopenia in African children can predict the severity of malaria caused by Plasmodium falciparum and the prognosis of the disease. Am J Trop Med Hyg 2003; 68:379; author reply 380-1.
32. Gourley IS, Kurtis JD, Kamoun M, Amon JJ, Duffy PE. Profound bias in interferon-gamma and interleukin-6 allele frequencies in western Kenya, where severe malarial anemia is common in children. J Infect Dis 2002; 186:1007-12.
33. Kirito K, Osawa M, Morita H et al. A functional role of Stat3 in in vivo megakaryopoiesis. Blood 2002; 99:3220-7.
34. De Souza JB, Williamson KH, Otani T, Playfair JH. Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun 1997; 65:1593-8.
35. Haque A, Graille M, Kasper LH, Haque S. Immunization with heat-killed Toxoplasma gondii stimulates an early IFN-gamma response and induces protection against virulent murine malaria. Vaccine 1999; 17:2604-11.
36. Sarawar SR, Cardin RD, Brooks JW, Mehrpooya M, Tripp RA, Doherty PC. Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol 1996; 70:3264-8.
37. Sarawar SR, Cardin RD, Brooks JW et al. Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J Virol 1997; 71:3916-21.
38. Christensen JP, Cardin RD, Branum KC, Doherty PC. CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci U S A 1999; 96:5135-40.
39. Rhee MS, Akanmori BD, Waterfall M, Riley EM. Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria. Clin Exp Immunol 2001; 126:503-10.
40. Stevenson PG, Cardin RD, Christensen JP, Doherty PC. Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol 1999; 80:477-83.